Impax Labs
Home Up Feedback

Help support   A Jazz Tea, When - August 10, 2008,  Where - Robert Treat Hotel, Newark, N.J.  - MG: Memorial Golf Classic - Where - Crestmont Country Club - When - August  18, 2008,   Walk-A-Thon, When - May 10, 2008, Where - Immaculate Heart of Mary Church, 580 Ratzer Road, Wayne, NJ.

Home
Up

 

Impax wins FDA approval for neuromuscular drug

Susan L. Thomas  

Impax Laboratories Inc. of Hayward said the U.S. Food and Drug Administration has approved its abbreviated new drug application for a generic version of Mestinon, a drug to treat a neuromuscular disorder, the company said Monday.

INC Pharmaceuticals Inc. markets Mestinon 60-milligram tablets for the symptomatic treatment of myasthenia gravis, a neuromuscular disorder characterized primarily by muscle weakness and rapid muscle fatigue. IMS Health puts U.S. sales of Mestinon at $19 million in 2002, according to Impax.

Top of Page